Code Biotherapeutics Alternatives & Competitors
12 companies similar to Code Biotherapeutics — Pioneering targeted delivery of precision genetic medicines
Companies similar to Code Biotherapeutics
Gennao Bio
A genetic medicines company developing first-in-class, targeted nucleic acid therapeutics
Hopewell, United States
Solid Biosciences
#TogetherWeAreSolid
Boston, United States
Dyne Therapeutics
Advancing life-transforming therapies for serious muscle diseases
Waltham, United States
United Kingdom
Rival Readout
Competing with Code Biotherapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Affinia Therapeutics
Building the next generation of gene therapies
Waltham, United States
Kelonia Therapeutics
Revolutionizing in vivo gene delivery to usher in a new era of genetic medicines.
Boston, United States
Hopewell Therapeutics, Inc.
Enabling a new generation of genomic medicines for patients with high unmet medical needs.
Woburn, United States
AIRNA
The next generation of RNA editing therapeutics
Cambridge, United States
bluebird bio
Pursuing curative gene therapies to give patients and their families more bluebird days.
Somerville, United States
AskBio Inc.
Pioneering science to create transformative molecular medicines.
United States
AAVantgarde
Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the...
Exegenesis Bio
We are reimagining ways to develop & manufacture gene therapies. Our mission is to improv...
Philadelphia, United Stat...
About Code Biotherapeutics
Code Biotherapeutics is a trailblazer in the field of genetic medicine, dedicated to the development of precision therapies for individuals affected by genetic disorders. Founded in 2020, this United States-based company operates at the intersection of Biotechnology, Health Care, and Life Sciences. The driving force of...
Development of genetic medicines, Non-viral DNA delivery technology, Research in rare diseases
Healthcare providers, Patients with life-threatening diseases, Biopharma partners, Research institutions
Precision Genetic Medicines, Gene Therapy, Genetic Diseases, Non-viral Delivery, 3DNA Platform, Duchenne Muscular Dystrophy, Synthetic DNA, Targeted Delivery, Re-dosability, Bioavailability, Vector Manufacturing, Rare Diseases, Internal Pipeline, Targeted Non-viral Gene Therapies, Biotechnology Partnerships
B2B, B2D, Platform
Licensing, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Code Biotherapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Code Biotherapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
